Home » Stocks » TMCI

Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts will go public soon. The estimated IPO date is April 23, 2021.
Stock Price: $15.00 - $17.00
Current IPO price range
Market Cap 807.40M
Revenue (ttm) 57.37M
Net Income (ttm) -4.31M
Shares Out 50.46M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Hide News

Ponte Vedra-based company plans to reach the market this week.

20 hours ago - Jax Daily Record

Treace Medical Concepts, Inc. has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC

About TMCI

Treace Medical Concepts is a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions). We have pioneered our proprietary Lapiplasty 3D Bunion Correction System – a combination of novel instruments, implants and surgical methods designed to improve the inconsistent clinical outcomes of traditional approaches to bunion surgery. Although bunions are deformities typically caused by an unstable joint in the middle of the foot that leads to a three-dimensiona... [Read more...]

Industry
Surgical & Medical Instruments
IPO Date
Apr 23, 2021
CEO
John T. Treace
Employees
133
Stock Exchange
NASDAQ
Ticker Symbol
TMCI
Full Company Profile

Financial Performance

In 2020, TMCI's revenue was $57.37 million, an increase of 45.54% compared to the previous year's $39.42 million. Losses were -$3.67 million, -14.00% less than in 2019.

Financial Statements